TABLE 2.
Positive predictive values comparing algorithms of ICD-9 and ICD-10 claims-based diagnoses of CKD Stages 3–5 to eGFR based on laboratory values
| Algorithm | ICD-9 period 2012–2014 | ICD-10 period 2016–2018 |
|---|---|---|
| 1 CKD diagnosis, lab ± 90 days | N = 146 739 | N = 380 117 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 81.24 (81.04, 81.44) | 82.00 (81.87, 82.12) |
| Comparison to eGFR (MDRD) | 81.89 (81.70, 82.09) | 82.03 (81.91, 82.15) |
|
| ||
| 2 CKD diagnoses, lab ± 90 days | N = 104 774 | N = 285 520 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 86.36 (86.15, 86.57) | 86.07 (85.94, 86.20) |
| Comparison to eGFR (MDRD) | 86.67 (86.47, 86.88) | 85.93 (85.80, 86.06) |
|
| ||
| 1 CKD diagnosis, lab ± 180 days | N = 155 730 | N = 386 331 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 80.32 (80.12, 80.52) | 81.56 (81.43, 81.68) |
| Comparison to eGFR (MDRD) | 80.91 (80.71, 81.10) | 81.46 (81.34, 81.59) |
|
| ||
| 2 CKD diagnoses, lab ± 180 days | N = 110 540 | N = 286 745 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 85.30 (85.09, 85.51) | 85.56 (85.43, 85.69) |
| Comparison to eGFR (MDRD) | 85.60 (85.40, 85.81) | 85.30 (85.17, 85.43) |
|
| ||
| 1 CKD diagnosis, lab ± 365 days | N = 161 305 | N = 373 220 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 78.80 (78.61, 79.00) | 80.63 (80.50, 80.76) |
| Comparison to eGFR (MDRD) | 79.21 (79.01, 79.41) | 80.40 (80.27, 80.52) |
|
| ||
| 2 CKD diagnoses, lab ± 365 days | N = 111 329 | N = 270 553 |
|
| ||
| PPV (%), 95% CI | ||
| Comparison to eGFR (CKD-EPI) | 84.06 (83.84, 84.27) | 84.81 (84.67, 84.94) |
| Comparison to eGFR (MDRD) | 84.12 (83.91, 84.34) | 84.41 (84.27, 84.54) |
Note: Lab assessment window is described by the X-days lab label. For example, the 90-days lab label describes an analysis in which patients had a creatinine laboratory value 90 days before or after their claims-based CKD diagnosis.
Abbreviations: CKD-EPI, chronic kidney disease epidemiology collaboration; MDRD, the modification of diet in renal disease.